ArticleFrontiers in chemistry2025
UHPLC-HRMS analysis combined with feature-based molecular networking methods for systematic identification of chemicals in AnShenDingZhiLing and its absorbed metabolites.
Article in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: AnShenDingZhiLing is an effective Chinese herbal formula that is clinically used to treat pediatric attention deficit hyperactivity disorder (ADHD). In terms of the overall prescription, it has shown great efficacy in alleviating ADHD symptoms and holds broad clinical application prospects. However, due to the lack of Methods: In this study, we established a rapid and efficient method employing the UHPLC-HRMS system and integrated multiple strategies to systematically characterize and identify the chemical profiles and drug metabolites in the biological samples of AnShenDingZhiLing and AnShenDingZhiLing-treated rats. Results and discussion: 243 compounds (including 60 flavonoids, 50 terpenoids, 24 phenylpropanoids, 18 alkaloids, 18 anthraquinones, 16 phenylethanoid glycosides, 13 phenolic acids, nine xanthones, nine oligosaccharides, eight phthaleins, eight naphthopyrones, four organic acids, four aromatic aldehydes, and two diarylheptanoids) were characterized. Following the administration of AnShenDingZhiLing to rats, a total of 110 compounds related to Chinese herbal medicine ingredients were identified in the plasma and cerebrum samples. The primary metabolic pathways of chemicals derived from AnShenDingZhiLing can be summarized in methylation, demethylation, hydrolysis, hydroxylation, sulfation, and glucuronidation. In summary, through this rapid and accurate analytical method, the comprehensive chemical profiles of AnShenDingZhiLing and its metabolites were characterized. Additionally, in this study, we provide essential analytical thinking and scientific evidence for exploring the material basis of AnShenDingZhiLing efficacy further.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.